Sign In

Print this! Bookmark and Share


2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

Top of page


  Risk factors for adverse outcomes by left ventricular ejection fraction in a contemporary heart failure population. Allen LA, Magid DJ, Gurwitz JH, Smith DH, Goldberg RJ, Saczynski J, Thorp ML, Hsu G, Sung SH, Go AS. Circ Heart Fail 2013;6:635-46.

  Guideline Concordance of Testing for Hyperkalemia and Kidney Dysfunction During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients with Heart Failure. Allen LA, Shetterly S, Peterson PN, Gurwitz JH, Smith DH, Brand DW, Fairclough DL, Rumsfeld JS, Masoudi FA, Magid DJ. Circ Heart Fail 2013.

  Development of a multi-institutional cohort to facilitate cardiovascular disease biomarker validation using existing biorepository samples linked to electronic health records. Cross DS, McCarty CA, Steinhubl SR, Carey DJ, Erlich PM. Clin Cardiol 2013;36:486-91.

  Patterns of care and persistence after incident elevated blood pressure. Daley MF, Sinaiko AR, Reifler LM, Tavel HM, Glanz JM, Margolis KL, Parker E, Trower NK, Chandra M, Sherwood NE, Adams K, Kharbanda EO, Greenspan LC, Lo JC, O'Connor PJ, Magid DJ. Pediatrics 2013;132:e349-55.

  Sex differences in cardiovascular outcomes in patients with incident hypertension. Daugherty SL, Masoudi FA, Zeng C, Ho PM, Margolis KL, O'Connor PJ, Go AS, Magid DJ. J Hypertens 2013;31:271-7.

  Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction. Gurwitz JH, Magid DJ, Smith DH, Goldberg RJ, McManus DD, Allen LA, Saczynski JS, Thorp ML, Hsu G, Sung SH, Go AS. Am J Med 2013;126:393-400.

  Prehypertension and Hypertension in Community-Based Pediatric Practice. Lo JC, Sinaiko A, Chandra M, Daley MF, Greenspan LC, Parker ED, Kharbanda EO, Margolis KL, Adams K, Prineas R, Magid D, O'Connor PJ. Pediatrics 2013.

  Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS. J Am Heart Assoc 2013;2:e005694.

  Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes. O'Connor PJ, Vazquez-Benitez G, Schmittdiel JA, Parker ED, Trower NK, Desai JR, Margolis KL, Magid DJ. Diabetes Care 2013;36:322-7.

  Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. Peterson PN, Varosy PD, Heidenreich PA, Wang Y, Dewland TA, Curtis JP, Go AS, Greenlee RT, Magid DJ, Normand SL, Masoudi FA. Jama 2013;309:2025-34.

  Patterns of Comorbidity in Older Adults with Heart Failure: The Cardiovascular Research Network PRESERVE Study. Saczynski JS, Go AS, Magid DJ, Smith DH, McManus DD, Allen L, Ogarek J, Goldberg RJ, Gurwitz JH. J Am Geriatr Soc 2013;61:26-33.

  A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, Reynolds K, Go AS. J Am Heart Assoc 2013;2:e000250.

  Chronic Kidney Disease and Outcomes in Heart Failure With Preserved Versus Reduced Ejection Fraction: The Cardiovascular Research Network PRESERVE Study. Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, Hsu G, Sung SH, Magid DJ, Go AS. Circ Cardiovasc Qual Outcomes 2013;6:333-42.




 Health System Factors and Antihypertensive Adherence in a Racially and Ethnically Diverse Cohort of New Users. Adams AS, Uratsu C, Dyer W, Magid D, O'Connor P, Beck A, Butler M, Ho PM, Schmittdiel JA. Arch Intern Med 2012:1-8.

   Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults with Chronic Kidney Disease. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Circulation 2012.

   Targeted maximum likelihood estimation for prediction calibration. Brooks J, van der Laan MJ, Go AS. Int J Biostat 2012;8:30.

   Detection and recognition of hypertension in anxious and depressed patients. Byrd JB, Powers JD, Magid DJ, Tavel HM, Schmittdiel JA, O'Connor PJ, Beck AL, Butler MG, Ho PJ. J Hypertens 2012;30:2293-8.

   The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Daugherty SL, Powers JD, Magid DJ, Masoudi FA, Margolis KL, O'Connor PJ, Schmittdiel JA, Ho PM. Hypertension 2012;60:303-9.

   Incidence and prognosis of resistant hypertension in hypertensive patients. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM. Circulation 2012;125:1635-42.

   Thirty-day mortality after ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation on and off anticoagulants. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Stroke 2012;43:1795-9.

   Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Circ Cardiovasc Qual Outcomes 2012;5:e78-85.

   Comparative Effectiveness of 2 beta-Blockers in Hypertensive Patients. Parker ED, Margolis KL, Trower NK, Magid DJ, Tavel HM, Shetterly SM, Ho PM, Swain BE, O'Connor PJ. Arch Intern Med 2012:1-7.

   Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF and ATRIA Study Cohorts. Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM. Circulation 2012.

  A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures .  Vigen R, Shetterly S, Magid DJ, O'Connor PJ, Margolis KL, Schmittdiel J, Ho PM. Circ Cardiovasc Qual Outcomes 2012;5:276-82. 




  Combination therapy as initial treatment for newly diagnosed hypertension. Byrd JB, Zeng C, Tavel HM, Magid DJ, O'Connor PJ, Margolis KL, Selby JV, Ho PM. Am Heart J 2011;162:340-6.

   Do sex differences exist in patient preferences for cardiovascular testing? Daugherty SL, Magid DJ. Ann Emerg Med 2011;57:561-2.

   Age-dependent gender differences in hypertension management. Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, Selby JV, O'Connor PJ, Margolis KL, Magid DJ. J Hypertens 2011;29:1005-11.

   A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. J Am Coll Cardiol 2011;58:395-401.

   Impact of medication nonadherence on hospitalizations and mortality in heart failure. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. J Card Fail 2011;17:664-9.

   Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Clin J Am Soc Nephrol 2011;6:2605-11.

   Health literacy and outcomes among patients with heart failure. Peterson PN, Shetterly SM, Clarke CL, Bekelman DB, Chan PS, Allen LA, Matlock DD, Magid DJ, Masoudi FA. Jama 2011;305:1695-701.

   Missed opportunities in cardiovascular disease prevention?: low rates of hypertension recognition for women at medicine and obstetrics-gynecology clinics. Schmittdiel J, Selby JV, Swain B, Daugherty SL, Leong TK, Ho M, Margolis KL, O'Connor P, Magid DJ, Bibbins-Domingo K. Hypertension 2011;57:717-22.






   Warfarin discontinuation after starting warfarin for atrial fibrillation. Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. Circ Cardiovasc Qual Outcomes 2010;3:624-31.

   Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Ho PM, Tsai TT, Maddox TM, Powers JD, Carroll NM, Jackevicius C, Go AS, Margolis KL, DeFor TA, Rumsfeld JS, Magid DJ. Circ Cardiovasc Qual Outcomes 2010;3:261-6.

   Adverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. Ho PM, Tsai TT, Wang TY, Shetterly SM, Clarke CL, Go AS, Sedrakyan A, Rumsfeld JS, Peterson ED, Magid DJ. Circ Cardiovasc Qual Outcomes 2010;3:303-8.

   Trends in first-line therapy for hypertension in the Cardiovascular Research Network Hypertension Registry, 2002-2007. Ho PM, Zeng C, Tavel HM, Selby JV, O'Connor PJ, Margolis KL, Magid DJ. Arch Intern Med 2010;170:912-3.

   Blood pressure trajectories and associations with treatment intensification, medication adherence, and outcomes among newly diagnosed coronary artery disease patients. Maddox TM, Ross C, Tavel HM, Lyons EE, Tillquist M, Ho PM, Rumsfeld JS, Margolis KL, O'Connor PJ, Selby JV, Magid DJ. Circ Cardiovasc Qual Outcomes 2010;3:347-57.

   Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertension. Magid DJ, Shetterly SM, Margolis KL, Tavel HM, O'Connor PJ, Selby JV, Ho PM. Circ Cardiovasc Qual Outcomes 2010;3:453-8.

   Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease. McNeal CJ, Dajani T, Wilson D, Cassidy-Bushrow AE, Dickerson JB, Ory M. Curr Atheroscler Rep 2010;12:20-8.

   Association of longitudinal measures of hemoglobin and outcomes after hospitalization for heart failure. Peterson PN, Magid DJ, Lyons EE, Clarke CL, Zeng C, Fitzgerald A, Lindenfeld J, Kosiborod M, Brand D, Masoudi FA. Am Heart J 2010;159:81-9.

   PS1-06: The Impact of Treatment Intensification and Medication Adherence in Achieving Blood Pressure Control Among Coronary Artery Disease Patients. Ross C, Maddox T, Lyons E, Tavel H, Magid D. Clin Med Res 2010;8:204.

   Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. Selby JV, Lee J, Swain BE, Tavel HM, Ho PM, Margolis KL, O'Connor PJ, Fine L, Schmittdiel JA, Magid DJ. Hypertension 2010;56:605-11.

  Digoxin in patients with atrial fibrillation: no increase of mortality risk. Steuer, J. Praxis (Bern 1994). 2010 Jun 9;99(12):737-8. 

   C-C1-01: Building the Hypertension Registry: Adventures in Using the VDW Model. Tavel H, Defor T, Swain B, Schneider N, Lee J, Shetterly S, O'Connor P, Selby J, Magid D. Clin Med Res 2010;8:188-9.

   Increased risk of bleeding in patients on clopidogrel therapy after drug-eluting stents implantation: insights from the HMO Research Network-Stent Registry (HMORN-stent). Tsai TT, Ho PM, Xu S, Powers JD, Carroll NM, Shetterly SM, Maddox TM, Rumsfeld JS, Margolis K, Go AS, Magid DJ. Circ Cardiovasc Interv 2010;3:230-5.





   Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS. Circ Cardiovasc Qual Outcomes 2009;2:297-304.

   Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Steiner JF, Ho PM, Beaty BL, Dickinson LM, Hanratty R, Zeng C, Tavel HM, Havranek EP, Davidson AJ, Magid DJ, Estacio RO. Circ Cardiovasc Qual Outcomes 2009;2:451-7.



   The Cardiovascular Research Network: a new paradigm for cardiovascular quality and outcomes research. Go AS, Magid DJ, Wells B, Sung SH, Cassidy-Bushrow AE, Greenlee RT, Langer RD, Lieu TA, Margolis KL, Masoudi FA, McNeal CJ, Murata GH, Newton KM, Novotny R, Reynolds K, Roblin DW, Smith DH, Vupputuri S, White RE, Olson J, Rumsfeld JS, Gurwitz JH. Circ Cardiovasc Qual Outcomes 2008;1:138-47.

   Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease. Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS. Arch Intern Med 2008;168:271-6.

   Creating a research data network for cardiovascular disease: the CVRN. Magid DJ, Gurwitz JH, Rumsfeld JS, Go AS. Expert Rev Cardiovasc Ther 2008;6:1043-5.

   Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities. Somkin CP, Altschuler A, Ackerson L, Tolsma D, Rolnick SJ, Yood R, Weaver WD, Von Worley A, Hornbrook M, Magid DJ, Go AS. Contemp Clin Trials 2008;29:646-53.





    Digoxin and mortality in atrial fibrillation: a prospective cohort study.  Hallberg P, Lindback J, Lindahl B, Stenestrand U, Melhus H. Eur J Clin Pharmacol 2007;63:959-71.

Managed by Kaiser Permanente Division of Reseasrch
Content in this Web site is the property of CVRN - Cardiovascular Research Network. All rights reserved, ©